These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 6435861

  • 1. Antitumor properties of (2R,5R)-6-heptyne-2,5-diamine, a new potent enzyme-activated irreversible inhibitor of ornithine decarboxylase, in rodents.
    Bartholeyns J, Mamont P, Casara P.
    Cancer Res; 1984 Nov; 44(11):4972-7. PubMed ID: 6435861
    [Abstract] [Full Text] [Related]

  • 2. Comparative antitumor properties in rodents of irreversible inhibitors of L-ornithine decarboxylase, used as such or as prodrugs.
    Claverie N, Mamont PS.
    Cancer Res; 1989 Aug 15; 49(16):4466-71. PubMed ID: 2501026
    [Abstract] [Full Text] [Related]

  • 3. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
    Bakic M, Chan D, Freireich EJ, Marton LJ, Zwelling LA.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6437-43. PubMed ID: 2824033
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines.
    Pera PJ, Kramer DL, Sufrin JR, Porter CW.
    Cancer Res; 1986 Mar 15; 46(3):1148-54. PubMed ID: 3080234
    [Abstract] [Full Text] [Related]

  • 5. Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice.
    Bowlin TL, Hoeper BJ, Rosenberger AL, Davis GF, Sunkara PS.
    Cancer Res; 1990 Aug 01; 50(15):4510-4. PubMed ID: 2114941
    [Abstract] [Full Text] [Related]

  • 6. Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats.
    Bartholeyns J, Koch-Weser J.
    Cancer Res; 1981 Dec 01; 41(12 Pt 1):5158-61. PubMed ID: 6796266
    [Abstract] [Full Text] [Related]

  • 7. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
    Regenass U, Mett H, Stanek J, Mueller M, Kramer D, Porter CW.
    Cancer Res; 1994 Jun 15; 54(12):3210-7. PubMed ID: 8205541
    [Abstract] [Full Text] [Related]

  • 8. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.
    Bartholeyns J, Bouclier M.
    Cancer Res; 1984 Feb 15; 44(2):639-45. PubMed ID: 6692368
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of the antitumor therapeutic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor.
    Marton LJ, Levin VA, Hervatin SJ, Koch-Weser J, McCann PP, Sjoerdsma A.
    Cancer Res; 1981 Nov 15; 41(11 Pt 1):4426-31. PubMed ID: 6796258
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive effects of (2R,5R)-6-heptyne-2,5-diamine, an inhibitor of polyamine synthesis: II. Beneficial effects on the development of a lupus-like disease in MRL-lpr/lpr mice.
    Claverie N, Pasquali JL, Mamont PS, Danzin C, Weil-Bousson M, Siat M.
    Clin Exp Immunol; 1988 May 15; 72(2):293-8. PubMed ID: 3409547
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
    Slotkin TA, Seidler FJ, Trepanier PA, Whitmore WL, Lerea L, Barnes GA, Weigel SJ, Bartolome J.
    J Pharmacol Exp Ther; 1982 Sep 15; 222(3):741-5. PubMed ID: 6809932
    [Abstract] [Full Text] [Related]

  • 15. New S-adenosylmethionine decarboxylase inhibitors with potent antitumor activity.
    Regenass U, Caravatti G, Mett H, Stanek J, Schneider P, Müller M, Matter A, Vertino P, Porter CW.
    Cancer Res; 1992 Sep 01; 52(17):4712-8. PubMed ID: 1511437
    [Abstract] [Full Text] [Related]

  • 16. Effect of alpha-difluoromethylornithine, an enzyme-activated irreversible inhibitor of ornithine decarboxylase, on L1210 leukemia in mice.
    Prakash NJ, Schechter PJ, Grove J, Koch-Weser J.
    Cancer Res; 1978 Sep 01; 38(9):3059-62. PubMed ID: 679213
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antitumor activity of norspermidine, a structural homologue of the natural polyamine spermidine.
    Prakash NJ, Bowlin TL, Davis GF, Sunkara PS, Sjoerdsma A.
    Anticancer Res; 1988 Sep 01; 8(4):563-8. PubMed ID: 3140710
    [Abstract] [Full Text] [Related]

  • 20. Effects of (2R, 5R)-6-heptyne-2,5-diamine, a potent inhibitor of L-ornithine decarboxylase, on rat hepatoma cells cultured in vitro.
    Mamont PS, Siat M, Joder-Ohlenbusch AM, Bernhardt A, Casara P.
    Eur J Biochem; 1984 Aug 01; 142(3):457-63. PubMed ID: 6468373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.